Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
2.83 USD 0.02 ( 0.71%)
Last update at 2026-11-06T15:09:00Z
VOLUME
691255
Market Cap
1503.03M

Momentum Score

…

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.75
Low
2.84
High
52 Week Price Range
1.50
Low
3.40
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Tilray Brands Inc is a global cannabis and consumer products company that cultivates, manufactures and distributes medical and adult-use cannabis, hemp-derived products and related consumer packaged goods in North America and international markets. Long-term growth may be supported by progressive legalization trends, expansion into new jurisdictions and efficiencies from larger production and branded offerings.

Principal investment risks are regulatory uncertainty across jurisdictions, intense competition and pricing pressure in the cannabis sector, and execution and profitability challenges as the company integrates operations and seeks sustainable cash flow.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.81
Dividend Yield
-
Revenue TTM
743.25M
Revenue Per Share
1.04
Gross Profit TTM
116.82M
Debt / Equity
0.18
ROE
-9.69%
Net Debt
383.50M
ROCE
3.96%
Diluted EPS TTM
-0.43

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -440.67M -344.99M -58.19M -58.19M -11.56M
Minority interest -9.66M -42.67M 6.24M 25.81M 28.41M
Net income -434.13M -336.01M -61.02M -61.02M -12.19M
Selling general administrative 162.80M 111.58M 88.30M 88.30M 70.83M
Selling and marketing expenses 65.86M 44.12M 29.92M 29.92M 20.67M
Gross profit 116.82M 123.18M 137.68M 137.68M 55.74M
Reconciled depreciation 130.15M 115.19M 18.65M 15.85M 3.56M
Ebit 153.29M -4.95M -33.41M 51.48M -2.60M
Ebitda 268.49M 30.27M 2.11M 67.16M 14.36M
Depreciation and amortization 115.19M 35.22M 35.52M 15.68M 16.95M
Non operating income net other - - -36.35M - -6.18M
Operating income 153.29M -4.95M -47.62M 51.48M -2.60M
Other operating expenses 856.92M 581.64M 389.07M 389.07M 222.44M
Interest expense 39.68M 30.90M 24.78M 24.78M 5.75M
Tax provision -7.18M -6.54M -5.60M -8.45M -4.45M
Interest income 33.02M 11.74M 2.93M 0.76M 16.34M
Net interest income -13.59M -27.94M -39.22M -33.93M -9.11M
Non recurring - - 61.11M - -
Income tax expense -6.54M -8.97M 2.82M 2.82M 0.63M
Total revenue 628.37M 513.09M 391.00M 391.00M 175.25M
Total operating expenses 345.37M 191.74M 135.75M 135.75M 102.94M
Cost of revenue 511.56M 389.90M 253.31M 253.31M 119.50M
Total other income expense net -593.97M -340.04M -10.57M -109.68M -8.96M
Net income from continuing ops -1443.00M -434.13M -271.07M -321.17M -67.72M
Net income applicable to common shares - -434.13M -271.07M -321.17M -67.72M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4307.26M 5449.69M 6025.36M 1801.23M 1801.23M
Intangible assets 973.78M 1277.88M 1605.92M 261.73M 261.73M
Other current assets 37.72M 46.79M 48.92M 42.92M 51.42M
Total liab 977.32M 1008.33M 1560.05M 475.89M 475.89M
Total stockholder equity 3315.69M 4398.81M 4459.07M 1306.74M 1306.74M
Deferred long term liab - - - 49.27M -
Other current liab 18.04M 119.09M 138.82M 138.82M 4.62M
Common stock 0.07M 0.05M 0.05M 1331.54M 1331.54M
Capital stock - 0.07M 0.05M 0.05M 1331.54M
Retained earnings -2415.51M -962.85M -486.05M -44.13M -44.13M
Other liab - - 196.83M 53.89M 59.02M
Good will 2008.84M 2641.30M 2832.79M 445.50M 445.50M
Other assets - - 111.51M 4.36M 7.86M
Cash 206.63M 415.91M 488.47M 358.47M 358.47M
Total current liabilities 432.98M 280.34M 401.24M 122.84M 122.84M
Current deferred revenue 119.86M - 155.11M 0.65M 0.65M
Net debt 383.50M 207.90M 450.19M -58.15M -58.15M
Short term debt 224.26M 92.65M 49.60M 7.44M 7.44M
Short long term debt - 221.84M 85.95M 45.34M 1.50M
Short long term debt total 590.13M 623.81M 938.66M 300.32M 300.32M
Other stockholder equity 5777.74M 5382.37M 4792.41M 20.24M 20.24M
Property plant equipment - - 600.50M 199.56M 201.73M
Total current assets 773.03M 803.50M 883.61M 651.22M 651.22M
Long term investments - 12.37M 15.00M 23.67M 35.63M
Net tangible assets - - 479.62M 20.54M -106.81M
Short term investments 241.90M 241.90M - 9.30M 11.45M
Net receivables 86.23M 95.28M 89.79M 59.27M 50.77M
Long term debt - 357.93M 519.83M 306.26M 430.21M
Inventory 200.55M 245.53M 256.43M 190.56M 190.56M
Accounts payable 70.82M 68.60M 57.71M 110.12M 110.12M
Accumulated other comprehensive income -46.61M -20.76M 152.67M -0.91M -0.91M
Common stock total equity - - - 1846.94M 0.01M
Retained earnings total equity - - - -730.10M -
Non currrent assets other 0.22M 111.51M 8.29M 8.29M 0.00M
Non current assets total 3534.23M 4646.19M 5141.75M 1150.01M 1150.01M
Capital lease obligations - 10.36M 18.03M 33.54M 31.88M
Long term debt total - - - 306.26M 444.36M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -285.11M -21.53M 0.30M -253.18M -44.88M
Change to liabilities - -44.65M -30.76M 20.00M 14.64M
Total cashflows from investing activities - -21.53M -41.68M -253.18M -98.62M
Net borrowings - -123.55M 44.79M -1.00M 417.65M
Total cash from financing activities 128.20M 124.31M 125.40M 125.40M 535.51M
Change to operating activities - 4.47M -15.68M -23.11M 6.83M
Net income -434.13M -336.01M -61.02M -61.02M -12.19M
Change in cash -72.56M 127.82M -38.62M -38.62M 362.94M
Begin period cash flow 488.47M 360.65M 397.09M 397.09M 44.15M
End period cash flow 415.91M 488.47M 358.47M 358.47M 407.09M
Total cash from operating activities -177.26M -44.72M -96.43M -96.43M -41.10M
Issuance of capital stock 129.59M 262.51M 102.55M 71.90M 181.76M
Depreciation 154.59M 67.83M 35.52M 35.52M 16.95M
Other cashflows from investing activities - - 2.66M -2.69M -3.55M
Dividends paid -7484.00M - - - -
Change to inventory -45.75M -35.29M -90.25M -90.25M -29.17M
Change to account receivables -5.84M -23.51M -24.73M -24.73M 9.21M
Sale purchase of stock -1.19M - 96.97M 111.52M 228.65M
Other cashflows from financing activities 7482.64M 87.38M 63.07M 63.07M 362.16M
Change to netincome - 236.72M 183.10M 157.98M 29.32M
Capital expenditures 34.06M 38.87M 95.47M 95.47M 152.23M
Change receivables - - 6.29M - -16.41M
Cash flows other operating - - -15.81M - -2.59M
Cash and cash equivalents changes - - 93.82M - 486.13M
Change in working capital -91.77M -50.94M -82.96M -82.96M -15.88M
Stock based compensation 35.99M 17.35M 16.22M 16.22M 19.28M
Other non cash items 185.59M 281.92M -2.24M -2.24M -46.23M
Free cash flow -211.33M -83.59M -191.90M -191.90M -193.33M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TLRY
Tilray Inc
0.02
0.71%
2.83 - 1000.00 1.90 0.42 2.24 -12.95
MKKGY
Merck KGaA ADR
-0.24
0.72%
33.16 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
169.88 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-0.24
1.13%
20.95 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

Tilray Inc

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

265 Talbot Street West, Leamington, ON, Canada, N8H 5L4

844-845-7291

1600

Name Title Year Born
Mr. Irwin David Simon Pres, CEO & Chairman 1958
Mr. Carl A. Merton CA, CBV, CPA CFO & Principal Accounting Officer 1970
Mr. Mitchell S. Gendel Global Gen. Counsel & Corp. Sec. 1966
Mr. James R. Meiers Sr. VP of U.S. Operations 1958
Ms. Denise Menikheim Faltischek Chief Strategy Officer & Head of International 1973
Mr. Lloyd Brathwaite Chief Information Officer NA
Mr. Roger Savell Chief Admin. Officer NA
Mr. John B. Sadler VP of Investor Relations NA
Ms. Dara S. Redler Interim Chief Legal Officer & Corp. Sec. NA
Mr. Bernard Yeung Sr. VP of Sales & Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…